Paul E. Mann's most recent trade in ASP Isotopes Inc was a trade of 1,000,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Sept. 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2025 | 1,000,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 08 Sep 2025 | 1,000,000 | 8,399,734 | - | 2 | 2,000,000 | Common Stock |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.53 per share. | 08 Sep 2025 | 234,466 | 8,165,268 | - | 8.5 | 1,999,995 | Common Stock |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2025 | 216,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 08 Sep 2025 | 216,000 | 7,450,378 | - | 2 | 432,000 | Common Stock |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.39 per share. | 08 Sep 2025 | 81,077 | 8,084,191 | - | 8.4 | 680,123 | Common Stock |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 08 Sep 2025 | 81,076 | 7,234,378 | - | 8.5 | 691,408 | Common Stock |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.53 per share. | 08 Sep 2025 | 50,644 | 7,399,734 | - | 8.5 | 431,993 | Common Stock |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.75 per share. | 15 Apr 2025 | 316,667 | 7,948,787 | - | 5.8 | 1,821,944 | Common Stock |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.45 per share. | 15 Apr 2025 | 316,667 | 7,632,120 | - | 5.4 | 1,724,378 | Common Stock |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.62 per share. | 15 Apr 2025 | 316,666 | 7,315,454 | - | 5.6 | 1,780,075 | Common Stock |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2025 | 1,441,361 | 8,265,454 | - | - | Common Stock | |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 978,466 | 6,824,093 | - | - | Common Stock | |
| ASP Isotopes Inc | Paul E. Mann | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Jul 2024 | 39,984 | 5,845,627 | - | - | Common Stock | |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 718,143 | 5,805,643 | - | 0 | Common Stock | |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 1,000,000 | 5,087,500 | - | 0 | Common Stock | |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 1,000,000 | 4,087,500 | - | 0 | Common Stock | |
| ASP Isotopes Inc | Paul E. Mann | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 15 Nov 2022 | 37,500 | 3,087,500 | - | 4 | 150,000 | Common Stock |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2022 | 13,400 | 16,907 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 49,084 | 49,084 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 38,590 | 38,590 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Sale of securities on an exchange or to another person at price $ 2.38 per share. | 19 Feb 2021 | 45,566 | 0 (0%) | 0% | 2.4 | 108,502 | Common Stock |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 45,566 | 0 | - | - | Stock Option (Right to Buy) | |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.28 per share. | 19 Feb 2021 | 45,566 | 45,566 (0%) | 0% | 1.3 | 58,324 | Common Stock |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Sale of securities on an exchange or to another person at price $ 2.34 per share. | 17 Feb 2021 | 132,664 | 0 (0%) | 0% | 2.3 | 310,168 | Common Stock |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Sale of securities on an exchange or to another person at price $ 1.59 per share. | 18 Dec 2020 | 17,079 | 772,907 (0%) | 0% | 1.6 | 27,099 | Common Stock |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Sale of securities on an exchange or to another person at price $ 1.49 per share. | 02 Dec 2020 | 30,488 | 789,986 (0%) | 0% | 1.5 | 45,369 | Common Stock |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2020 | 45,566 | 45,566 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Nov 2020 | 45,566 | 0 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 02 Nov 2020 | 30,488 | 820,474 (0%) | 0% | 1.0 | 31,589 | Common Stock |
| Abeona Therapeutics Inc | Paul E. Mann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2020 | 813,008 | 850,962 (1%) | 0% | 0 | Common Stock |